You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and Zogenix undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

SUMAVEL ®, DosePro ®, Relday TM and Zohydro TM ER are trademarks of Zogenix, Inc.

SABER ® is a trademark of DURECT Corporation.
CONTACT: Investor Contact         Zack Kubow | The Ruth Group         646.536.7020 | zkubow@theruthgroup.com                  Media Contact         Caitlin Cox | The Ruth Group         646.536.7033 | ccox@theruthgroup.com

If you liked this article you might like

Biotech Premarket Movers: ChemoCentryx, Jazz, Ionis, Zogenix

These 5 Stocks Under $10 Could Light Up Soon

17 Thoughts on Biotech Stocks to Kick Off 2017

Depomed Reports Dip in Earnings, Reduces Revenue Guidance

Humana, Pharma Stocks Sink as Healthcare is Worst Performing Sector Wednesday